Iterum Therapeutics PLC (ITRMF) vs NexImmune, Inc. (NEXI)
- Iterum Therapeutics PLC ITRMF 0.00 NaN
- NexImmune, Inc. NEXI 0.00 NaN
Iterum Therapeutics PLC and NexImmune, Inc. are both Biotechnology companies. Iterum Therapeutics PLC and NexImmune, Inc. are of similar size ($1.6M and $1.6M). NexImmune, Inc. has the higher net margin (0.00% vs −2,930.5%) and the higher return on invested capital (0.00% vs −455.5%). Across the 11 metrics below, NexImmune, Inc. leads on 6 and Iterum Therapeutics PLC on 5.
Valuation
Profitability
| Metric | ITRMF | NEXI | Biotechnology median |
|---|---|---|---|
| Gross margin | (81.85%) | 0.00% | 65.16% |
| Operating margin | (2,243.48%) | 0.00% | 0.00% |
| Net margin | (2,930.54%) | 0.00% | 0.00% |
| Free cash flow margin | (2,122.61%) | 0.00% | 0.00% |
| Return on equity | 285.48% | (232.97%) | (56.36%) |
| Return on assets | (111.35%) | (140.56%) | (48.04%) |
| Return on invested capital | (455.51%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack